314 related articles for article (PubMed ID: 24039033)
1. Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers.
Binnewijzend MA; Adriaanse SM; Van der Flier WM; Teunissen CE; de Munck JC; Stam CJ; Scheltens P; van Berckel BN; Barkhof F; Wink AM
Hum Brain Mapp; 2014 May; 35(5):2383-93. PubMed ID: 24039033
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease.
Skouras S; Falcon C; Tucholka A; Rami L; Sanchez-Valle R; Lladó A; Gispert JD; Molinuevo JL
Neuroimage Clin; 2019; 22():101777. PubMed ID: 30913531
[TBL] [Abstract][Full Text] [Related]
3. Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
Skouras S; Torner J; Andersson P; Koush Y; Falcon C; Minguillon C; Fauria K; Alpiste F; Blenow K; Zetterberg H; Gispert JD; Molinuevo JL;
Brain; 2020 Mar; 143(3):976-992. PubMed ID: 32091109
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic functional connectivity alterations in cognitively intact elderly APOE ε4 carriers measured by eigenvector centrality mapping are related to cognition and CSF biomarkers: a preliminary study.
Luo X; Qiu T; Jia Y; Huang P; Xu X; Yu X; Shen Z; Jiaerken Y; Guan X; Zhou J; Zhang M;
Brain Imaging Behav; 2017 Oct; 11(5):1290-1301. PubMed ID: 27714554
[TBL] [Abstract][Full Text] [Related]
5. Disrupted Brain Network in Progressive Mild Cognitive Impairment Measured by Eigenvector Centrality Mapping is Linked to Cognition and Cerebrospinal Fluid Biomarkers.
Qiu T; Luo X; Shen Z; Huang P; Xu X; Zhou J; Zhang M;
J Alzheimers Dis; 2016 Oct; 54(4):1483-1493. PubMed ID: 27589525
[TBL] [Abstract][Full Text] [Related]
6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic functional connectivity, CSF biomarker profiles and their relation to cognitive function in mild cognitive impairment.
Matura S; Köhler J; Reif A; Fusser F; Karakaya T; Scheibe M; Ehret F; Hartmann D; Kang JS; Mayer C; Prvulovic D; Pantel J
Acta Neuropsychiatr; 2020 Aug; 32(4):206-213. PubMed ID: 31801648
[TBL] [Abstract][Full Text] [Related]
9. A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
Hafkemeijer A; Möller C; Dopper EG; Jiskoot LC; van den Berg-Huysmans AA; van Swieten JC; van der Flier WM; Vrenken H; Pijnenburg YA; Barkhof F; Scheltens P; van der Grond J; Rombouts SA
J Alzheimers Dis; 2017; 55(2):521-537. PubMed ID: 27662284
[TBL] [Abstract][Full Text] [Related]
10. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
[TBL] [Abstract][Full Text] [Related]
11. The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease.
Adriaanse SM; Wink AM; Tijms BM; Ossenkoppele R; Verfaillie SC; Lammertsma AA; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
Brain Connect; 2016 Feb; 6(1):1-8. PubMed ID: 26414628
[TBL] [Abstract][Full Text] [Related]
12. Default mode network connectivity is linked to cognitive functioning and CSF Aβ1-42 levels in Alzheimer's disease.
Celebi O; Uzdogan A; Oguz KK; Has AC; Dolgun A; Cakmakli GY; Akbiyik F; Elibol B; Saka E
Arch Gerontol Geriatr; 2016; 62():125-32. PubMed ID: 26515126
[TBL] [Abstract][Full Text] [Related]
13. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
[TBL] [Abstract][Full Text] [Related]
14. Functional brain network centrality is related to APOE genotype in cognitively normal elderly.
Wink AM; Tijms BM; Ten Kate M; Raspor E; de Munck JC; Altena E; Ecay-Torres M; Clerigue M; Estanga A; Garcia-Sebastian M; Izagirre A; Martinez-Lage Alvarez P; Villanua J; Barkhof F; Sanz-Arigita E
Brain Behav; 2018 Sep; 8(9):e01080. PubMed ID: 30136422
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
Li X; Westman E; Thordardottir S; Ståhlbom AK; Almkvist O; Blennow K; Wahlund LO; Graff C
J Alzheimers Dis; 2017; 56(1):327-334. PubMed ID: 27911308
[TBL] [Abstract][Full Text] [Related]
16. CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.
Fjell AM; Amlien IK; Westlye LT; Stenset V; Fladby T; Skinningsrud A; Eilsertsen DE; Bjørnerud A; Walhovd KB
Neuroimage; 2010 Jan; 49(2):1820-30. PubMed ID: 19800012
[TBL] [Abstract][Full Text] [Related]
17. The impact of cognitive reserve on brain functional connectivity in Alzheimer's disease.
Bozzali M; Dowling C; Serra L; Spanò B; Torso M; Marra C; Castelli D; Dowell NG; Koch G; Caltagirone C; Cercignani M
J Alzheimers Dis; 2015; 44(1):243-50. PubMed ID: 25201783
[TBL] [Abstract][Full Text] [Related]
18. Altered topological patterns of brain networks in mild cognitive impairment and Alzheimer's disease: a resting-state fMRI study.
Liu Z; Zhang Y; Yan H; Bai L; Dai R; Wei W; Zhong C; Xue T; Wang H; Feng Y; You Y; Zhang X; Tian J
Psychiatry Res; 2012 May; 202(2):118-25. PubMed ID: 22695315
[TBL] [Abstract][Full Text] [Related]
19. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.
Vemuri P; Wiste HJ; Weigand SD; Shaw LM; Trojanowski JQ; Weiner MW; Knopman DS; Petersen RC; Jack CR;
Neurology; 2009 Jul; 73(4):294-301. PubMed ID: 19636049
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
